Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Molecular Carcinogenesis|January 30, 2016
Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expressionOns Zakraoui, Cezary Marcinkiewicz, Zohra Aloui, et al.
Circulation Research|April 7, 2007
Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesisIzabela Staniszewska, Shachi Zaveri, Luis Del Valle, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
RETRACTED: Naamneh et al. Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549Majdi Saleem Naamneh, Tatjana Momic, Michal Klazas, et al.
Experimental Cell Research|October 1, 2003
Role of multiple beta1 integrins in cell adhesion to the disintegrin domains of ADAMs 2 and 3Monika Tomczuk, Yuji Takahashi, Jing Huang, et al.
International Journal of Molecular Sciences|July 2, 2021
Interactions via α2β1 Cell Integrin May Protect against the Progression of Airway Structural Changes in AsthmaStanislawa Bazan-Socha, Bogdan Jakiela, Joanna Zuk, et al.
Experimental Cell Research|December 31, 2003
RGD- and MLD-disintegrins, jarastatin and EC3, activate integrin-mediated signaling modulating the human neutrophils chemotaxis, apoptosis and IL-8 gene expressionAna Lucia J Coelho, Marta S De Freitas, Andrea Mariano-Oliveira, et al.
Cellular Signalling|March 10, 2015
Association of p75(NTR) and α9β1 integrin modulates NGF-dependent cellular responsesErin M Ventresca, Shimon Lecht, Piotr Jakubowski, et al.
Developmental Cell|November 9, 2021
Controlling tissue patterning by translational regulation of signaling transcripts through the core translation factor eIF3cKotaro Fujii, Olena Zhulyn, Gun Woo Byeon, et al.
JACS Au|January 3, 2022
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple SclerosisChaim Gilon, Michal Klazas, Adi Lahiani, et al.
Neurotoxicology|July 13, 2010
Peaceful use of disastrous neurotoxicantsYoram Finkelstein, Dejan Milatovic, Philip Lazarovici, et al.
Pageof 10